Cardiff Oncology Statistics
NASDAQ: CRDFHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.08+0.02 (+1.89%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cardiff Oncology by the numbers
Cardiff Oncology has a market capitalization of $84.0 million based on 77.80M shares outstanding. With trailing EPS of $-0.60, Cardiff Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.7% below its 50-day average and 32.1% below its 200-day average.
Average daily trading volume is 1.04M shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRDF valuation vs. peer median
| Metric | CRDF | Peer median | Difference |
|---|---|---|---|
| Market cap | $84.02M | $80.94M | +4% |
| Avg. volume | 1.04M | 304.96K | +241% |
Peer median across 8 companies: CGTX, PTHS, NMRA, OKYO, ATRA, GRML, CSBR, BDTX.
Valuation
- Market cap
- $84.02M
- EPS (TTM)
- $-0.60
- Shares outstanding
- 77.80M
Price and trading
- Previous close
- 1.06
- Open
- 1.06
- Day range
- 1.06 – 1.11
- 52-week range
- 0.76 – 3.31
- 52-week change
- -54.62%
- Beta
- —
- Volume
- 297.23K
- Average volume
- 1.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 84.02M
- Forward Pe
- -2.02
- Eps
- -0.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.31
- Week52 Low
- 0.76
- Avg Volume
- 1.04M
- Shares Outstanding
- 77.80M
- Ma50
- 1.09
- Ma200
- 1.59
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -67.37%
- Pct From52w Low
- 42.11%